3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Lung Neoplasms
11
Carcinoma, Non-Small-Cell Lung
5
Thoracic Neoplasms
1
Solitary Pulmonary Nodule
1
Neoplasms by Site
1
Neoplasms
1
Multiple Pulmonary Nodules
1
Mesothelioma, Malignant
1
Lung Diseases
1
Esophageal Neoplasms
1
Interventions
Pemetrexed
7
Carboplatin
7
Cisplatin
5
pembrolizumab
4
durvalumab
4
osimertinib
3
Paclitaxel
3
selpercatinib
2
pralsetinib
2
cobimetinib
2
Radiosurgery
2
Erlotinib Hydrochloride
2
130-nm albumin-bound paclitaxel
2
trametinib
1
taletrectinib
1
sotorasib
1
repotrectinib
1
patritumab
1
napabucasin
1
glutathione pegylated liposomal doxorubicin
1
ficlatuzumab
1
exemestane
1
enzalutamide
1
entinostat
1
dabrafenib
1
ceralasertib
1
cemiplimab
1
camrelizumab
1
atezolizumab
1
alectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms by Site
×
Indocyanine Green
×
Thoracic
×
Clear all
NCT02111824
2021-09-17
MIMIG
The Methodist Hospital Research Institute
Phase 1
Terminated
7 enrolled